Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
about
Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccineVaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedlesMicroneedle-based drug and vaccine delivery via nanoporous microneedle arraysCutaneous immunization: an evolving paradigm in influenza vaccinesIncreased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.A protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches.Enabling skin vaccination using new delivery technologies.Kinetics of skin resealing after insertion of microneedles in human subjects.Delivery systems for intradermal vaccinationCoating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug.Visualization of plasmid delivery to keratinocytes in mouse and human epidermis.Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression.DNA vaccination in the skin using microneedles improves protection against influenza.Microneedles for drug and vaccine deliveryMicroneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticlesMeasles vaccination using a microneedle patchIn Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers.Microneedle arrays as medical devices for enhanced transdermal drug delivery.Hepatitis C virus-mediated modulation of cellular immunity.Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications.Microneedle patches for vaccine delivery.Advanced materials and nanotechnology for drug delivery.Electroporation for therapeutic DNA vaccination in patients.Polymer multilayer tattooing for enhanced DNA vaccination.Microneedles: an innovative platform for gene delivery.Microneedle patches for vaccination in developing countries.Mucosal vaccine delivery: Current state and a pediatric perspectiveThe success of microneedle-mediated vaccine delivery into skin.Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch.Transdermal delivery devices: fabrication, mechanics and drug release from silk.Chitin microneedles for an easy-to-use tuberculosis skin test.Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.Smart microneedle coatings for controlled delivery and biomedical analysis.Efficient delivery of nucleic acid molecules into skin by combined use of microneedle roller and flexible interdigitated electroporation array.High Aspect Ratio Elongated Microparticles for Enhanced Topical Drug Delivery in Human Volunteers
P2860
Q27013822-67EB6EF0-E2D8-4BE4-BDBE-E290F7A223C0Q27311290-61BA29BB-6539-4568-95E3-79852585B064Q28085656-59B49731-2585-4CB5-B5BF-FB93D75C8F01Q30358895-8F965AA4-7327-4958-817E-276E41E7A293Q30415387-6C293DD7-41F8-4EC2-9DFE-39CFEEA2E6B1Q30430152-8B19D69D-74BA-4979-B3F9-68401A5895B1Q33964159-ADB98DFD-BF5E-411A-BE99-D6217722C16FQ34055422-D84209A9-9914-4477-84C9-61A66D1E310FQ35126354-9C673B1C-7006-47FF-AE1D-02CCDA055FB0Q35187866-DAE1F809-619F-4997-9B38-C203DA1D42C4Q35214379-F43F67D5-4A6F-4F02-A586-6E4F47C85828Q35219316-173C1EFC-3761-4837-B1BF-38E3F6B6CC54Q35619666-BC4AD7DE-D8DC-4697-B14F-8E3EF329DE6AQ36077060-CF094C37-3C5F-44D0-A0FA-12C5035BC7EAQ36085414-01CB3E9D-29F2-4850-B3A3-A8421F9BA82AQ36164749-64B18F1B-0A96-4B00-BA00-5167031237DEQ36339297-FC982460-4B60-4A15-BD70-A326AF8934C4Q36997297-C46588ED-C44B-4661-8C72-AA84FF966771Q37682217-311A31ED-BE85-4B81-A93D-68DC1F8DFBF4Q37897542-5EE7682B-1C6B-4B74-AC4D-207D253735E5Q38036576-2CC514FF-96E8-4D3B-A1F5-A97BC43E1A31Q38105616-1C73E651-EF0E-44A2-965F-CC12F9FE33C2Q38178693-CC49DD08-ECA8-47AC-9AD5-4B786FA3FB07Q38180643-AC50FCA6-2BC4-4DA3-8D2E-316F5D4640B6Q38298562-3F0405E6-E2CE-4297-873C-35C3A178F2EFQ38499608-E8A4141E-8DEB-4F7A-998B-80CDB28EBEF3Q38539948-4BB4DB6A-6CCD-4928-A546-E9EFD4A2EE3EQ38646712-0C27578C-A7A5-49CA-80BA-531E4BF5949AQ38727453-FDEC6C2C-8565-4FC8-A2CE-5B2E78B8516AQ38799509-CE22DA7C-B189-4254-974B-0F96017BCE3EQ39186224-E1BE7909-8E19-4FC3-B570-97CDE9FDA879Q40073524-445CE4FF-4380-4F5C-A050-07689674C063Q41828287-23F1C958-6405-4B4C-83B8-037EB4C096AAQ43746709-B8AEB5A9-9552-45F3-94BA-878453A9A636Q46044056-3F55BAB1-9D2A-48A6-A818-2FC1759B8F09Q51514678-119E8E43-0F65-416A-AF8F-01B6FD2EC978Q55002159-752FA894-651A-4F89-AC56-C49C459ACAD3Q57732812-DA54838F-205A-4F0B-B17B-B120FC31ED8E
P2860
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@ast
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@en
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@nl
type
label
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@ast
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@en
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@nl
prefLabel
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@ast
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@en
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@nl
P2093
P2860
P356
P1433
P1476
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
@en
P2093
J Söderholm
M R Prausnitz
M Sällberg
P2860
P2888
P304
P356
10.1038/GT.2010.22
P577
2010-03-04T00:00:00Z